2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation …
H Heidbuchel, P Verhamme, M Alings… - European heart …, 2017 - academic.oup.com
Abstract In 2013, the European Heart Rhythm Association (EHRA) published a Practical
Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation …
Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation …
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep …, 2015 - academic.oup.com
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Europace, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature
Background—Novel oral anticoagulants (NOACs) have been proposed as alternatives to
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
vitamin K antagonists for the prevention of stroke and systemic embolism in patients with …
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
H Heidbuchel, P Verhamme, M Alings… - European heart …, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis
M Grymonprez, C Simoens, S Steurbaut… - EP …, 2022 - academic.oup.com
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) are effective and safe
alternatives compared with vitamin K antagonists (VKAs) for thromboembolic prevention in …
alternatives compared with vitamin K antagonists (VKAs) for thromboembolic prevention in …
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral …
MV Huisman, GLORIA-AF Investigators, CS Ma… - EP …, 2016 - academic.oup.com
Aims The introduction of non-VKA oral anticoagulants (NOACs), which differ from the earlier
vitamin K antagonist (VKA) treatments, has changed the approach to stroke prevention in …
vitamin K antagonist (VKA) treatments, has changed the approach to stroke prevention in …
'Real-world'antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey
Background Current guidelines strongly recommend that oral anticoagulation should be
offered to patients with atrial fibrillation and≥ 1 stroke risk factors. The guidelines also …
offered to patients with atrial fibrillation and≥ 1 stroke risk factors. The guidelines also …